U.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa

Ducommun Incorporated

31/12/2024 08:08

Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Axsome Therapeutics, Ducommun and Vacasa
on Tuesday. 
    
    HIGHLIGHTS
                 * Axsome Therapeutics Inc  AXSM.O : Needham raises target price to $133
 from $130
 
                 * Ducommun Inc  DCO.N : RBC reinstates coverage with outperform rating
 
                 * Vacasa Inc  VCSA.O : Needham cuts to hold from buy
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
                 * Axsome Therapeutics Inc  AXSM.O : Needham raises target price to $133
 from $130
 
                 * Axsome Therapeutics Inc  AXSM.O : RBC raises target price to $138 from
 $132
 
                 * Cal-Maine Foods Inc  CALM.O : Stephens raises target price to $88 from
 $82
 
                 * Ducommun Inc  DCO.N : RBC reinstates coverage with outperform rating
 
                 * Ducommun Inc  DCO.N : RBC reinstates coverage with price target $72 vs
 $60
 
                 * Marinus Pharmaceuticals Inc  MRNS.O : Baird raises target price to $0.55
 from $0.50
 
                 * Vacasa Inc  VCSA.O : Needham cuts to hold from buy
 
                 * Verastem Inc  VSTM.O : BTIG raises target price to $20 from $13
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))